Thermo Completes Sale of Certain Assets to GE
News Mar 24, 2014
The businesses will become part of GE Healthcare’s Life Sciences division.
The combined revenue of the three businesses was $250 million in 2013. Thermo Fisher committed to sell these businesses to address regulatory concerns related to its acquisition of Life Technologies Corporation, which was completed on February 3, 2014.
New Class of Decoy Molecules that Prevent the Onset of PainNews
Researcher report a new method of reducing pain-associated behaviors with RNA-based medicine, creating a new class of decoy molecules that prevent the onset of pain.READ MORE
Scleroderma Study Offers New Hope For SufferersNews
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study found. The approach could represent the first new treatment to improve survival in patients with severe scleroderma in more than four decades.READ MORE